One company dominates with an approved therapy, while the other bets on in vivo innovation. See how their financials and risk ...

Researchers at Cornell University have developed a safer and more precise way to study how genes function in living tissues by refining a recently developed CRISPR-based genetic technique in fruit ...

Researchers at Cornell University have developed a safer and more precise way to study how genes function in living tissues by refining a recently developed CRISPR-based genetic technique in fruit ...

Every cell in every organism on Earth copies DNA the same way. Except one bacterial protein — quietly doing something ...

CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team are scheduled to participate in ...

Are there significant gains ahead for one (or both) of these innovative biotechs?

Banas is associate director of research at the Gene Editing Institute at ChristianaCare, where Kmiec is founder and executive director. The medical promise of CRISPR gene editing can be seen most ...

PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces the commercial ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. 22 May 2018, Germany, Berlin: A researcher performs a CRISPR/Cas9 process at the ...

Learn how CRISPR ETFs provide access to the gene-editing revolution, offering investors a diversified approach without picking individual biotech stocks.